Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-05-23
2006-05-23
Kerr, Kathleen M. (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S326000, C530S334000, C530S344000, C424S422000, C424S423000, C424S426000, C523S115000
Reexamination Certificate
active
07049293
ABSTRACT:
A peptide has any one of the sequences SEQ ID NO.1 to SEQ ID NO.8, or has a sequence derived from any one of the sequences SEQ ID NO.1 to SEQ ID NO.8 by substitution, deletion or addition of one or several amino acids therein and having an osteogenetic activity.
REFERENCES:
patent: 5028592 (1991-07-01), Lipton
patent: 6281195 (2001-08-01), Rueger et al.
patent: 99402815 (2000-09-01), None
patent: 06/296677 (1994-10-01), None
patent: 6/298800 (1994-10-01), None
patent: 07/088174 (1995-04-01), None
patent: 07/116240 (1995-09-01), None
patent: 07/246235 (1995-09-01), None
patent: 10/070989 (1998-03-01), None
patent: 10/151188 (1998-06-01), None
patent: WO 89/09787 (1989-10-01), None
patent: WO 89/09788 (1989-10-01), None
Database Biosis 'Online! Biosciences Information Service Philadelphia, PA, US: R. Bellamkonda, et al.: “Laminin oligopeptide derivatized agarose gels allow three-dimensional neurite extension in vivtro” XP002145150 & J. Neuroscience Research, 1995, vol. 41, pp. 501-509.
T.J. Gao, et al.: “Bone inductive potential and dose-dependent response of bovine bone morphogenetic protein combined with type IV collagen carrier” Annales Chirurgiae et Gynaecologiae, vol. 82, 1993, pp. 77-84.
S. Ijiri, et al., : “Ectopic bone induction in porous apatite-wollastonite-containing glass ceramic combined with bone morphogenetic protein” J. Biomed. Mater. Res., vol. 35, No. 4, Jun. 15, 1997 pp. 421-432.
Novel Regulators of Bone Formation: Molecular Clones and Activities; Wozney, et al. / Science, vol. 242: Research Articles, pp. 1528-1534 / Dec. 16, 1988.
“Recombinant human bone morphogenetic protein induces bone formation”; Wang, et al.; Proc. Natl. Acad.: Sci. USA, vol. 87, pp. 2220-2224, Mar. 1990, Biochemistry.
Nishimura Yoshihiko
Suzuki Yoshihisa
Tanihara Masao
Kam Chin-Min
Kerr Kathleen M.
Kyocera Corporation
LandOfFree
Peptide and osteogenetic accelerator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptide and osteogenetic accelerator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide and osteogenetic accelerator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3536897